Fulltext

Effectiveness of organised versus opportunistic mammography screening

Bulliard, J.-L ; Ducros, C. ; Jemelin, C. ; Arzel, B. ; Fioretta, G. ; Levi, F.

In: Annals of Oncology, 2009, vol. 20, no. 7, p. 1199-1202

Ajouter à la liste personnelle
    Titre
    • Effectiveness of organised versus opportunistic mammography screening
    Auteur
    • Bulliard, J.-L. Cancer Epidemiology Unit, University Institute of Social and Preventive Medicine (IUMSP), Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne
    • Ducros, C.. Breast Cancer Screening Foundation, Lausanne
    • Jemelin, C.. Valais Breast Cancer Screening Centre, Sion
    • Arzel, B.. Geneva Breast Cancer Screening Foundation, Geneva
    • Fioretta, G.. Geneva Cancer Registry, Institute of Social and Preventive Medicine, Geneva University, Geneva
    • Levi, F.. Cancer Epidemiology Unit, University Institute of Social and Preventive Medicine (IUMSP), Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne
    Type de document
    • Postprint
    Langue
    • Anglais
    Publié dans
    • Annals of Oncology, 2009, vol. 20, no. 7, p. 1199-1202. Oxford University Press
    Autre version électronique
    Identifiant OAI-PMH
    • oai:doc.rero.ch:304256
    Summary
    Background: Detailed comparison of effectiveness between organised and opportunistic mammography screening operating in the same country has seldom been carried out. Patients and methods: Prognostic indicators, as defined in the European Guidelines, were used to evaluate screening effectiveness in Switzerland. Matching of screening programmes' records with population-based cancer registries enabled to compare indicators of effectiveness by screening and detection modality (organised versus opportunistic screening, unscreened, interval cancers). Comparisons of prognostic profile were also drawn with two Swiss regions uncovered by service screening of low and high prevalence of opportunistic screening, respectively. Results: Opportunistic and organised screening yielded overall little difference in prognostic profile. Both screening types led to substantial stage shifting. Breast cancer prognostic indicators were systematically more favourable in Swiss regions covered by a programme. In regions without a screening programme, the higher the prevalence of opportunistic screening, the better was the prognostic profile. Conclusions: Organised screening appeared as effective as opportunistic screening. Mammography screening has strongly influenced the stage distribution of breast cancer in Switzerland, and a favourable impact on mortality is anticipated. Extension of organised mammography screening to the whole of Switzerland can be expected to further improve breast cancer prognosis in a cost-effective way